Psyence Biomedical (PBM)
4.12
-0.40 (8.85%)
Latest Headlines
Psyence BioMed completes $2.6M PsyLabs investment after milestones met
October 21, 2026 7:03 AM - StreetInsider
Form 6-K PSYENCE BIOMEDICAL LTD. For: Oct 21
October 21, 2026 7:00 AM - SEC Filing
Psyence BioMed Completes PsyLabs Investment as Ibogaine Milestones Are Met
October 21, 2026 7:00 AM - StreetInsider
Form SCHEDULE 13D/A PSYENCE BIOMEDICAL LTD. Filed by: Psyence Labs Ltd
October 15, 2026 9:03 AM - SEC Filing
Pacific Bay Weaver Lake Rock Sample Returns 0.78 Ounces per Ton Gold
October 6, 2026 8:03 AM - StreetInsider
Form SCHEDULE 13G PSYENCE BIOMEDICAL LTD. Filed by: AdvisorShares Trust
October 5, 2026 9:41 AM - SEC Filing
Psyence BioMed unit signs ibogaine manufacturing deal in Texas
October 5, 2026 7:03 AM - StreetInsider
Form 6-K PSYENCE BIOMEDICAL LTD. For: Oct 05
October 5, 2026 7:00 AM - SEC Filing
Psyence BioMed Partners with DEA-Registered Benuvia Operations to Establish U.S. Manufacture of Pharmaceutical-Grade Ibogaine
October 5, 2026 7:00 AM - StreetInsider
Psyence BioMed unit signs ibogaine license term sheet with PsyLabs
September 28, 2026 7:03 AM - StreetInsider
Form 6-K PSYENCE BIOMEDICAL LTD. For: Sep 28
September 28, 2026 7:00 AM - SEC Filing
Psyence BioMed Announces Exclusive U.S. Ibogaine Licence for Texas Ibogaine Research Corporation
September 28, 2026 7:00 AM - StreetInsider
Form 6-K PSYENCE BIOMEDICAL LTD. For: Sep 23
September 23, 2026 7:01 AM - SEC Filing
Psyence BioMed invests up to $5M in PsyLabs, forms Texas unit
September 23, 2026 7:00 AM - StreetInsider
Psyence BioMed Announces Strategic Ibogaine Investment
September 23, 2026 7:00 AM - StreetInsider
Form 6-K PSYENCE BIOMEDICAL LTD. For: Sep 14
September 14, 2026 7:34 AM - SEC Filing
Psyence BioMed Establishes Texas Ibogaine Research Corporation to Advance U.S. Ibogaine Development
September 14, 2026 7:00 AM - StreetInsider
Form S-8 PSYENCE BIOMEDICAL LTD.
August 26, 2026 6:02 AM - SEC Filing
Form F-3 PSYENCE BIOMEDICAL LTD.
August 26, 2026 6:02 AM - SEC Filing
Trump highlights ibogaine development push, Psyence BioMed responds
August 18, 2026 5:25 PM - StreetInsider
Psyence BioMed Welcomes U.S. Administration’s Latest Action to Accelerate Ibogaine Development
August 18, 2026 5:23 PM - Globe NewsWire
Form 6-K PSYENCE BIOMEDICAL LTD. For: Aug 06
August 6, 2026 4:02 PM - SEC Filing
Full Article List
